406 related articles for article (PubMed ID: 31284537)
21. Administration of JTE013 abrogates experimental asthma by regulating proinflammatory cytokine production from bronchial epithelial cells.
Terashita T; Kobayashi K; Nagano T; Kawa Y; Tamura D; Nakata K; Yamamoto M; Tachihara M; Kamiryo H; Nishimura Y
Respir Res; 2016 Nov; 17(1):146. PubMed ID: 27829417
[TBL] [Abstract][Full Text] [Related]
22. Recent Patents for the Treatment of Asthma.
El-Qutob D; Raducan I
Recent Pat Inflamm Allergy Drug Discov; 2016; 10(1):13-20. PubMed ID: 27262358
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes.
Barnes PJ
J Allergy Clin Immunol; 2015 Sep; 136(3):531-45. PubMed ID: 26343937
[TBL] [Abstract][Full Text] [Related]
24. TSLP Inhibitors for Asthma: Current Status and Future Prospects.
Matera MG; Rogliani P; Calzetta L; Cazzola M
Drugs; 2020 Apr; 80(5):449-458. PubMed ID: 32078149
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibodies for the treatment of asthma.
Catley MC; Coote J; Bari M; Tomlinson KL
Pharmacol Ther; 2011 Dec; 132(3):333-51. PubMed ID: 21944943
[TBL] [Abstract][Full Text] [Related]
26. Beyond type 2 cytokines in asthma - new insights from old clinical trials.
Choy DF; Arron JR
Expert Opin Ther Targets; 2020 May; 24(5):463-475. PubMed ID: 32223656
[No Abstract] [Full Text] [Related]
27. Novel cytokine-directed therapies for asthma.
Walsh GM
Discov Med; 2011 Apr; 11(59):283-91. PubMed ID: 21524382
[TBL] [Abstract][Full Text] [Related]
28. Targeting the interleukin pathway in the treatment of asthma.
Chung KF
Lancet; 2015 Sep; 386(9998):1086-96. PubMed ID: 26383000
[TBL] [Abstract][Full Text] [Related]
29. Cytokine antagonists for the treatment of asthma: progress to date.
Antoniu SA
BioDrugs; 2009; 23(4):241-51. PubMed ID: 19697966
[TBL] [Abstract][Full Text] [Related]
30. Targeting airway inflammation: novel therapies for the treatment of asthma.
Walsh GM
Curr Med Chem; 2006; 13(25):3105-11. PubMed ID: 17073650
[TBL] [Abstract][Full Text] [Related]
31. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies.
Chung KF
J Intern Med; 2016 Feb; 279(2):192-204. PubMed ID: 26076339
[TBL] [Abstract][Full Text] [Related]
32. Cytokine/anti-cytokine therapy - novel treatments for asthma?
Hansbro PM; Kaiko GE; Foster PS
Br J Pharmacol; 2011 May; 163(1):81-95. PubMed ID: 21232048
[TBL] [Abstract][Full Text] [Related]
33. Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma.
Herbert C; Hettiaratchi A; Webb DC; Thomas PS; Foster PS; Kumar RK
Clin Exp Allergy; 2008 May; 38(5):847-56. PubMed ID: 18307529
[TBL] [Abstract][Full Text] [Related]
34. Cytokine and anti-cytokine therapy in asthma: ready for the clinic?
Desai D; Brightling C
Clin Exp Immunol; 2009 Oct; 158(1):10-9. PubMed ID: 19737225
[TBL] [Abstract][Full Text] [Related]
35. 18β-Glycyrrhetinic acid, the major bioactive component of Glycyrrhizae Radix, attenuates airway inflammation by modulating Th2 cytokines, GATA-3, STAT6, and Foxp3 transcription factors in an asthmatic mouse model.
Kim SH; Hong JH; Lee JE; Lee YC
Environ Toxicol Pharmacol; 2017 Jun; 52():99-113. PubMed ID: 28410469
[TBL] [Abstract][Full Text] [Related]
36. Characterization of asthma endotypes: implications for therapy.
Stokes JR; Casale TB
Ann Allergy Asthma Immunol; 2016 Aug; 117(2):121-5. PubMed ID: 27499539
[TBL] [Abstract][Full Text] [Related]
37. Biologic and New Therapies in Asthma.
Tabatabaian F; Ledford DK; Casale TB
Immunol Allergy Clin North Am; 2017 May; 37(2):329-343. PubMed ID: 28366480
[TBL] [Abstract][Full Text] [Related]
38. Targeted anti-IL-13 therapies in asthma: current data and future perspectives.
Ntontsi P; Papathanassiou E; Loukides S; Bakakos P; Hillas G
Expert Opin Investig Drugs; 2018 Feb; 27(2):179-186. PubMed ID: 29334288
[TBL] [Abstract][Full Text] [Related]
39. Peucedanum japonicum extract attenuates allergic airway inflammation by inhibiting Th2 cell activation and production of pro-inflammatory mediators.
Chun JM; Lee AR; Kim HS; Lee AY; Gu GJ; Moon BC; Kwon BI
J Ethnopharmacol; 2018 Jan; 211():78-88. PubMed ID: 28919220
[TBL] [Abstract][Full Text] [Related]
40. Patient stratification and the unmet need in asthma.
Swedin L; Saarne T; Rehnberg M; Glader P; Niedzielska M; Johansson G; Hazon P; Catley MC
Pharmacol Ther; 2017 Jan; 169():13-34. PubMed ID: 27373855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
